You are here
GUIDED THERAPEUTICS
UEI: EED4JJEKE5V1
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Instacortisol: A realtime and continuous assessment of cortisol in ISF
Amount: $1,059,931.00DESCRIPTION (provided by applicant): Repetitive exposures to psychosocial stress are associated with several human diseases (e.g., cancer, drug addiction, heart disease, depression) of noteworthy publ ...
SBIRPhase II2011Department of Health and Human Services National Institutes of Health -
InstaCortisol:A realtime and continuous assessment of Cortisol in ISF
Amount: $189,504.00DESCRIPTION (provided by applicant): StressSmart Repeated exposures to psychosocial stress are associated with several human diseases (e.g., cancer, drug addiction, heart disease, depression) of tre ...
SBIRPhase I2009Department of Health and Human Services National Institutes of Health -
Economic Spectroscopic Evaluation of Cervical Cancer
Amount: $2,517,120.00DESCRIPTION (provided by applicant): Guided Therapeutics has developed the LightTouch(R), a non invasive, point of care device that uses a combination of fluorescence and reflectance spectroscopy to m ...
SBIRPhase II2009Department of Health and Human Services National Institutes of Health -
Multimodal Spectroscopic Evaluation of Cervical Cancer
Amount: $690,829.00DESCRIPTION (provided by applicant): Cervical Cancer is the second most common type of cancer in women worldwide and the leading cause of cancer related mortality in women in developing countries. Ear ...
SBIRPhase II2006Department of Health and Human Services National Institutes of Health -
Economic spectroscopic evaluation of Cervical Cancer
Amount: $1,003,230.00DESCRIPTION (provided by applicant): Cervical Cancer is the second most common type of cancer in women worldwide and the leading cause of cancer related mortality in women in developing countries. E ...
SBIRPhase II2005Department of Health and Human Services National Institutes of Health -
Economic spectroscopic evaluation of Cervical Cancer
Amount: $101,625.00DESCRIPTION (provided by applicant): Cervical Cancer is the second most common type of cancer in women worldwide and the leading cause of cancer related mortality in women in developing countries. E ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
Multimodal Spectroscopic Evaluation of Cervical Cancer.
Amount: $0.00DESCRIPTION (provided by applicant): Cervical Cancer is the second most common type of cancer in women worldwide and the leading cause of cancer related mortality in women in developing countries. ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health -
MULTIMODAL SPECTROSCOPIC EVALUATION OF CERVICAL CANCER
Amount: $129,555.00DESCRIPTION (Verbatim from the Applicant's Abstract): Cervical cancer is the second most common cause of cancer in women worldwide and the leading cause of cancer related mortality in wo ...
SBIRPhase I2001Department of Health and Human Services National Institutes of Health